Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBEREST: Telbivudine kinetics in CHB
NCT00640588Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00640588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640588.